BioSpace News Archive

Dicerna Pharmaceuticals, Inc. today announced that the Company will be added to the NASDAQ Biotechnology Index (Nasdaq:NBI) as part of the annual re-ranking, which will become effective prior to market open on Monday, December 24, 2018.

-- Agenus Conference Call Scheduled for Today at 8:30 a.m. ET --

Kypha, a medical diagnostics company with an innovative testing platform for precision monitoring of immune system activity to improve patient care and advance immune-targeted drug development, has secured $4 million in Series A funding led by Arsenal Capital Management.

After the M&A wave died down in 2018, many analysts thought the so-called “Green Rush” was over, but we think they were wrong.

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019 at 3:30pm Pacific time / 6:30pm Eastern time.

WW and Blue Apron Debut Exclusive WW Freestyle™ Menu, Available to All Beginning December 26

Ocular Therapeutix’s addition to the NBI will become effective prior to market open on Monday, December 24, 2018.

The Company expects to initiate the study in the first half of 2019.

Jenny Craig, a leader in the weight loss industry, announced today their 2019 ad campaign, which focuses on actual Jenny Craig members and weight loss experts, and their stories of finding health and wellness on the program.

Myovant Sciences (NYSE: MYOV), a leading clinical-stage biopharmaceutical company focused on women’s health and endocrine diseases, today announced that Lynn Seely, M.D., President and Chief Executive Officer of Myovant Sciences, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.